Introduction
============

Cancer is regarded as a complex disease which is non-curable in most cases (Dalkic et al., 2010[@B9]). Breast and cervical cancers are the most common cancers in women in Iran and worldwide. Breast cancer continues to be a major health problem for women. Cervical cancer is one of the most common cancers in Iran and worldwide and the second most common cancer in Iran (Farahmandbeigi et al., 2000[@B19]). Unfortunately, this cancer is developing rapidly. Current systemic therapies for these cancers are often limited by their non-specific effects, normal tissues toxicity and short-term efficacy due to the emergence of drug resistance (Mousavi et al., 2009[@B21]). The main strategy of chemotherapy protocols is a synergistic damaging effect of drugs on cancer cells with reduced toxicity to the host.

Currently, using medicinal plants is regarded as an effective strategy for treatment of various cancers. So, the application of some compounds that are derived from plants has been established in various cancer therapeutic regimens. However, there is still a great need to find new sources.

*Perovskia abrotanoides* (*P. abrotanoides*) is a medicinal plant which belongs to Lamiaceae family, grows wild in Iran, Afghanistan, Pakistan and Turkmenistan (SafaeiGhomi and Batooli, 2010[@B22]). This perennial herb is distributed in North, East and Central regions of Iran. *P. abrotanoides* is a valuable medicinal species in northern Iran (Iran, North Khorasan). This plant is self-propelled, specially for cold and dry regions, and is used in traditional medicine (Mazandarani, 2010[@B20]). This plant contains flavonoids, phenolics and anthocyanins (Mazandarani, 2010[@B20]). Phytochemical study conducted on roots of *P. abrotanoides* in 2001 showed that the root contains diterpenoid 1,2-quinones which are called tanshinones (Sairafianpour et al., 2001[@B23]).

Tanshinones have remarkably diverse biological activities that are important in medical sciences. For example, anti-microbial and fungal activity (Bolourian -- Kashy, 2007[@B7]), antioxidant (Zhou et al., 1999[@B26]; Fan et al., 2009[@B10]), anti-allergic, anti-inflammatory (Fan et al., 2009[@B10]; Fu et al., 2007[@B12]; Bai et al., 2008[@B4]) and anti-diabetes (Kim et al., 2007[@B17]) effects have been reported for them. They also protect human umbilical vein endothelial cells injured by hydrogen peroxide (Lin et al., 2006[@B18]) and cardiac myocytes against oxidative stress (Fu et al., 2007[@B12]). Also, protection against cardiotoxsicity (Jiang et al., 2009[@B15]), anti-cardiomyocyte hypertrophia (Yang et al., 2007[@B25]), reduction of cardiac fibrosis (Fang et al., 2010[@B11]) and the expansion of the coronary artery (Bolourian -- Kashy, 2007[@B7]) are the other properties of this plant. Regulation of cytokine production (Choi et al., 2004[@B8]) and increasing learning and memory (Kim et al., 2009[@B16]) have also been attributed to these compounds. In recent years, studies have showed that tanshinones possess cytotoxic and apoptotic effects on some human cancer cell lines (Bolourian -- Kashy, 2007[@B7]; Fan et al., 2009[@B10]; Aoyagi et al., 2006[@B2]; Hazra et al., 2004[@B14]). Considering the fact that flowers and roots have completely different compounds (Mazandarani, 2010[@B20]) and also that apoptotic and anti-cancer effects of flower of this plant has not been investigated, this study was designed to examine *in vitro* anti-proliferative and proapoptotic effects of flower extract of *P. abrotanoides* on MCF-7 and Hela cell lines.

Materials and Methods
=====================

**Cell line and substances**

Hela and MCF-7 cell lines were obtained from Pasteur institute (Iran, Tehran). 4, 5-dimethylthiazole-2-yl, 2, 5-diphenyl tetrazolium (MTT) and Dulbecco's phosphate-buffered saline (PBS) were purchased from Sigma (St Louis, MO, USA). Glucose-high Dulbecco's modified Eagle's medium (DMEM), glucose free DMEM, fetal bovine serum (FBS) and penicillin streptomycin were purchased from Gibco (Grand Island, NY). Dimethyl sulfoxide (DMSO) was purchased from Merck (Germany). Propidium iodide (PI), sodium citrate and Triton X-100 were purchased from Sigma (St. Louis, MO, USA).

**Cell culture and treatment**

Cells were cultured in Dulbecco's Modified Eagle's medium (DMEM) with 10% fetal bovine serum, 100 units/ml penicillin and 100 µg/ml streptomycin. Cells were then plated and incubated with various concentrations of extract for 24, 48 and 72 h. For MTT assay, cells were seeded at 7000/well on to 96-well culture plates. For each concentration and time course, there was a control sample which remained untreated and received the equal volume of medium. For assay of apoptosis, cells were seeded at 1×10^5^/well onto a 24-well plate (Mahdian et al., 2014). All different treatments were carried out in triplicate.

**Preparation of** ***P. abrotanoides*** **flower extraction**

*P. abrotanoides* flowers were collected from Dargaz mountains (Khorasan Razavi,Iran ). Flowers were dried at room temperature, powdered with a grinder, wrapped in cloths and then placed in soxhlet apparatus for one week and extracted with hydro-alcoholic extraction (ethanol 70% W/W). The extract was then dried on a water bath and (yield 24% w/w) dissolved in DMSO.

**Cell viability**

The cell viability was determined using a modified 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium (MTT) assay (Mahdian et al., 2014). Briefly, cells were seeded at 7×10^3^/well in flat-bottom 96-well culture plates and allowed to grow for 24 , 48 and 72h followed by treatment with extract at different concentrations (1-1000 µg/ml). After removing the medium, cells were incubated with MTT solution (5 mg/ml in PBS) for 4 h and the resulting formazan was solubilized with DMSO (100 µl). The absorption was measured at 570 nm (620 nm as a reference) using an ELISA reader.

All treatments were carried out in triplicate.

**Cell apoptosis assay**

Apoptotic cells were detected using PI staining of small DNA fragments followed by flow cytometry. It has been reported that a sub-G1 peak which is the reflective of DNA fragmentation can be observed following the incubation of cells with a hypotonic phosphate-citrate buffer containing a quantitative DNA-binding dye, such as PI. Apoptotic cells that have lost DNA take up less stain and appear on the left side of the G1 peak in the histogram. Briefly, Hela cells were seeded in a 24-well plate and treated with *P. abrotanoides* flower extract at different concentrations (10, 50, 100, 500, 1000µg/ml) for 24, 48 and 72h. Floating and adherent cells were then harvested and incubated with 750 μl of a hypotonic buffer (50 mg/ml PI in 0.1% sodium citrate with 0.1% Triton X-100) at 4 °C overnight in the dark. Next, flow cytometry was carried out using a FACScan flow cytometer (Becton Dickinson). A total of 1×10^4^ events were acquired with FACS. All treatments were carried out in triplicate.

**Statistical analysis**

One-way analysis of variance (ANOVA) and the Bonferroni post-hoc test were used for data analysis. All the results are expressed as the mean ± SEM, and p values below 0.05 were considered statistically significant.

Results
=======

**Effect of hydro-alcoholic extract of** ***P. abrotanoides*** **on Hela cell viability**

Hela cells were incubated with *P. abrotanoides* extract (1-1000 µg/ml) for 24, 48 and 72 h. Results showed that *P. abrotanoides* extract decreased cell viability in a time and dose-dependent manner ([Figure 1](#F1){ref-type="fig"}). After 24 and 72h, *P. abrotanoides* extract had no effect on Hela cell viability but After 48h, *P. abrotanoides* diminished cell viability at doses of 1000µg/ml (p\<0.001).

![Effect of hydro-alcholic extract of *P. abrotanoides* on viability of Hela cell. (A) Hela cells were treated with different concentrations of *P. abrotanoides* extract (1-1000 µg/ml) for 24h. (B) Hela cells were treated with different concentrations of *P. abrotanoides* extract (1-1000 µg/ml) for 48h. (C) Hela cells were treated with different concentrations of *P. abrotanoides* extract (1-1000 µg/ml) for 72 h. Viability was measured by MTT assay. Results are Mean ± SEM (n = 3). \*p \<0.05 , \*\*p \< 0.01 , \*\*\*p \< 0.001](AJP-6-410-g001){#F1}

**Effect of hydro-alcoholic extract of** ***P. abrotanoides*** **on MCF-7 cell viability**

MCF-7 cells were incubated with *P. abrotanoides* extract (100-1000 µg/ml) for 24, 48 and 72 h. The cell viability was quantified by MTT assay. The results showed that *P. abrotanoides* extract decreased cell viability in a time and dose-dependent manner ([Figure 2](#F2){ref-type="fig"}). After 24, 48 and 72 h, *P. abrotanoides* extract decreased cell viability significantly at concentration of 500 (p\<0.01) and 1000 µg/ml (p\<0.001).

![Effect of hydro-alcholic extract of *P. abrotanoides* on viability of MCF-7 cells. (A) MCF-7 cells were treated with different concentrations of *P. abrotanoides* extract (100-1000 µg/ml) for 24h. (B) MCF-7 cells were treated with different concentrations of PA extract (100-1000 µg/ml) for 48h. (C) MCF-7 cells were treated with different concentrations of *P. abrotanoides* extract (100-1000 µg/ml) for 72h. Viability was measured by MTT assay. Results are Mean ± SEM (n = 3). \*p \<0.05, \*\*p \< 0.01 , \*\*\*p \< 0.001](AJP-6-410-g002){#F2}

**Apoptosis induction using the hydro-alcoholic extraction of PA**

Apoptosis in MCF-7 cell line was detected with flow cytometry using PI staining. Cells were incubated for 24, 48 and 72h with various concentrations (10, 50, 100, 500 and 1000 µg/ml) of *P. abrotanoides* extract. Analysis of the sub-G1 peak in flow cytometry histograms revealed the induction of apoptosis in treated cells when compared with untreated control cells ([Figure 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). As shown in [Figure 3](#F3){ref-type="fig"}, 24 and 48h treatment with *P. abrotanoides* extract 500 µg/ml (p\<0.05) induced apoptosis significantly in MCF7 cell line even though at 72h, *P. abrotanoides* extract induced apoptosis only at 1000µg/ml.

![Role of apoptosis in *P. abrotanoides* extract induced toxicity in MCF7 cells. (A) MCF7 cells treated with DMEM medium as control and 10-1000 µg/ml of hydro-alcholic extract of *P. abrotanoides* after 24h. (B) MCF7 cells treated with DMEM medium as control and 10-1000 µg/ml of hydro-alcholic of *P. abrotanoides* extract after 48h. (C) MCF7 cells treated with DMEM medium as control and 10-1000 µg/ml of hydro-alcholic of *P. abrotanoides* extract after 72h.](AJP-6-410-g003){#F3}

![Role of apoptosis in *P. abrotanoides* extract-induced toxicity in MCF7 cells. (A) flow cytometry histograms of PI-stained MCF7 cells treated with DMEM medium (B) Flow cytometry histograms of PI-stained MCF7 cells treated with 500µg/ml of *P. abrotanoides*extract for 24h. (C) Flow cytometry histograms of PI-stained MCF7 cells treated with 500µg/ml of *P. abrotanoides* extract for 48h.(D) Flow cytometry histograms of PI-stained MCF7 cells treated with 1000µg/ml of *P. abrotanoides* extract for 72h. Sub-G1 peak as an indicative of apoptotic cells, was induced in *P. abrotanoides* extract-treated but not in control cells](AJP-6-410-g004){#F4}

Discussion
==========

Cancer is a growing health problem around the world. Considering the safety and efficacy of phytochemicals, molecular mechanistic research has focused on plants with cancer prevention potentials (Shu et al., 2010[@B24]). Changes in cell proliferation and cell death are basic determining factors in the pathogenesis of cancer. Anti-cancer phytochemicals can act either as cell cycle and apoptosis regulators, or as anti-oxidative stress and anti-inflammatory agents (Hanahan and Weinberg, 2000[@B13]). Various studies have revealed that essential oil extracted from *P. abrotanoides* stem and leaves could be a promising source of natural products with potential antioxidant activities, compared to fixed oil (Ashraf et al., 2014[@B3]). Anti-inflammatory and anti-pain effects of *P. abrotenoides*is have been mentioned in traditional medicine, as proved in modern animal model researches. According to reports, villagers in the Isfahan province of Iran applied a poultice made of crushed roots of the plant, water, sesame oil and wax, on lesions caused by cutaneous leishmaniasis. In Golestan, North Iran, *P. abrotenoides* is used to treat leishmaniasis and dermal problems. Aerial branches of Pabrotenoides have anti-inflammatory and anti-pain effects. In another study, the anti-plasmodium property of floral aerial of *P. abrotanoides* against *Plasmodium falciparum* and cytotoxic activity has been shown (Beikmohammadi, 2012[@B6]). Researchers indicate that ethanolic extracts of*salvia tribola and salvia dominica S. triloba* and *S. dominica* (lamiaceae family) may be useful in breast cancer management/treatment via pro-apoptotic cytotoxic mechanisms (Abu-Dahab et al., 2015[@B1]).

Throughout the present study, different concentrations of hydro-alcoholic extract of *P. abrotenoides* flowers were evaluated for possible cytotoxic/apoptotic activity. In addition, the extract was evaluated for apoptotic potential. According to our findings, the extract increased DNA fragmentation in MCF-7 cells as shown by the low fluorescent intensity of PI-stained cells in the flow cytometry histogram. These data suggest that the extract induced apoptosis in MCF-7 cells. Apoptotic cell populations (sub-G1 peak) of cells treated with the extract (500 and 1000 µg/ml) were increased in a time and concentration-dependent manner.

As shown in Hela cells, *P. abrotenoides* extract just following 48h incubation could inhibit the growth of cells. This finding might imply that during 72h incubation, compensatory mechanisms are activated, which in turn leads to cell growth in the presence of *P. abrotenoides* extract, and also diminishes the toxic effect of *P. abrotenoides* extract on cell growth.

The use of crude plant extracts in biological assays makes the synergistic and antagonistic evaluation of the phytochemicals possible. Moreover, biological evaluation of single components from plants eliminates the recognized inconsistencies found in extract preparations (Bandaranayake, 2006[@B5]).
